The disease is always preceded by a premalignant point out (MBL) which shares most molecular drivers with overt CLL. In many conditions, these molecular motorists continue to be continual eventually. Having said that, clonal evolution is also feasible and is frequently connected to exponential tumor expansion, progressive disease and, occasionally,